Cellular and culture medium proteomes from umbilical cord mesenchymal stem cell and human umbilical vein endothelial cells
Ontology highlight
ABSTRACT: Application of umbilical cord mesenchymal stem cell-derived conditioned media (HUCMSC-CM) to treat severe, progressive PAH. Serial infusions of HUCMSC-CM resulted in marked clinical and hemodynamic improvement after 6 months, and showed no adverse events. Differential expression analysis between conditioned media and cells was used to identify molecular processes with a putative role in treatment benefit.
INSTRUMENT(S): timsTOF Pro 2
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Endothelial Cell Of Umbilical Vein, Mesenchymal Stem Cell Of Umbilical Cord, Cell Culture
SUBMITTER: Michael Mülleder
LAB HEAD: Prof. Dr. Georg Hansmann
PROVIDER: PXD032234 | Pride | 2022-11-29
REPOSITORIES: Pride
ACCESS DATA